全文获取类型
收费全文 | 1460篇 |
免费 | 190篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 33篇 |
妇产科学 | 15篇 |
基础医学 | 115篇 |
口腔科学 | 40篇 |
临床医学 | 256篇 |
内科学 | 119篇 |
皮肤病学 | 15篇 |
神经病学 | 37篇 |
特种医学 | 45篇 |
外科学 | 76篇 |
综合类 | 230篇 |
预防医学 | 360篇 |
眼科学 | 4篇 |
药学 | 124篇 |
7篇 | |
中国医学 | 79篇 |
肿瘤学 | 107篇 |
出版年
2024年 | 6篇 |
2023年 | 29篇 |
2022年 | 62篇 |
2021年 | 86篇 |
2020年 | 115篇 |
2019年 | 70篇 |
2018年 | 74篇 |
2017年 | 55篇 |
2016年 | 65篇 |
2015年 | 56篇 |
2014年 | 112篇 |
2013年 | 121篇 |
2012年 | 88篇 |
2011年 | 104篇 |
2010年 | 95篇 |
2009年 | 68篇 |
2008年 | 76篇 |
2007年 | 72篇 |
2006年 | 66篇 |
2005年 | 49篇 |
2004年 | 37篇 |
2003年 | 29篇 |
2002年 | 35篇 |
2001年 | 17篇 |
2000年 | 13篇 |
1999年 | 20篇 |
1998年 | 9篇 |
1997年 | 7篇 |
1996年 | 9篇 |
1995年 | 8篇 |
1994年 | 5篇 |
1993年 | 2篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 3篇 |
1988年 | 2篇 |
1987年 | 3篇 |
1983年 | 1篇 |
1977年 | 1篇 |
排序方式: 共有1672条查询结果,搜索用时 15 毫秒
41.
目的:探讨MatriXX 2D矩阵电离室和X线模拟定位机应用于挡铅射野质量保证的方法及可靠性.方法:用MatriXX 2D矩阵电离室测得挡铅射野的形状和大小,应用Matlab编程绘制出治疗计划系统(treatment plan system,TPS)中相对应的射野的形状和大小;利用X线模拟定位机拍摄出射野挡铅的验证片并通过计算机上的RT PACS获取保存,对尺寸较大的射野,使用Photoshop图像处理软件合成出包含挡铅射野全部信息的验证片;从TPS调出相对应的包含挡铅射野信息的数字重建影像(digital reconstruction radiography,DRR).分别比较2对图片包含的射野信息.结果:对60个所测挡铅射野和计划射野进行比较,发现2种射野的形状总体上相符,3种方式的误差分别为(1.71±0.84)、(2.32±0.31)和(2.89±0.47)mm.结论:利用MatriXX 2D矩阵电离室和X线模拟定位机进行挡铅射野质量保证,简单易行、快速有效,能够满足放疗质控中对射野挡铅的要求. 相似文献
42.
43.
Objective To evaluate the current state of glycemie control in Chinese patients with type 2 diabetes mellitus who have received oral antidiabetic agents in the out-patient clinic,and the efficacy and safety of optimized regiments of gliclazide modified-release tablets (Diamicron MR, SERVIER, Tianjin) in patients with failed glycemic control (HbA1c 6.5%). Methods The patients with type 2 diabetes were enrolled from 54 hospitals in more than 20 cities and received long-term (more than 3 months) oral antidiabetic agents. HbA1c was measured and the success rate of HbA1c reduction was evaluated. The patients who failed to achieve glycemic control (HbA1c 6. 5%) and received daily multiple-dosing insulin secretagogues were provided with the optimized treatment regimen, consisting of replacing daily multiple-dosing insulin secretagogues with single-dosing gliclazide sustained-release tablets. Clinical efficacy and safety were evaluated after three months treatment. Results The survey of glycemic control revealed that the mean HbA1c of 5 586 patients with diabetes mellitus was (7.97±2.89)% ,and the success rate (HbA1c≤6.5%) was 14. 1%. Further more, HbA1c decreased from (8.23±4.00)% before optimization to (6.86±2.24)% after optimization with the average decrement of 1.37% (P<0. 001) and the success rate was raised to 34. 1%. The gliclazide modified-release tablets were well tolerated by most patients, only 2.6% of whom were reported to experience unconfirmed hypoglycemia. Conclusion The success rate of glycemic control was low in Chinese out-patients with type 2 diabetes mellitus receiving oral antidiabetic agents in the clinic. The optimized regimen of gliclazide modified-release tablets taken once daily can down-regulate glycemic levels and increase the success rate of HbA1c reduction,and thus plays efficiently and safely a key role in the optimized management of type 2 diabetes mellitus. 相似文献
44.
自2010年国际上倡导发展监管科学以来的10年间,对监管科学这一新学科的发展及其研究开发新的工具、标准和方法来评估受监管产品的安全性、有效性、质量和性能,为指导药物创新、评估、质量、安全性和有效性产生了积极作用。从6方面回顾和论述:(1)世界药品监管科学10年发展概况;(2)国际政府-产业-科学研究3方面的积极合作,特别是非政府机构推进国家管理部门重视监管科学的发展;(3)结合国情重视中药研发的监管科学建设;(4)推进生物技术药物监管科学的最新发展动向;(5)中国药品监管科学行动计划对提高监管水平的新引擎作用;(6)在疫情特殊时期监管科学为防控新冠肺炎(COVID-19)所获得的成绩和存在的问题。最后,为推进监管科学在我国的发展提出10条建议。 相似文献
45.
《Research in social & administrative pharmacy》2020,16(10):1370-1378
BackgroundMedication plans are instruments used to document drug therapies, guide patients, and ensure medication safety. In Germany, patients who take at least 3 long-term medications are eligible to receive a medication plan. It has been statutory to use the federal standard layout (German: “Bundeseinheitlicher Medikationsplan”) since April 2017.ObjectivesThis study explores the prevalence, availability, medication discrepancies, and conformance with statutory regulations of medication plans since the introduction of the format of the federal standard medication plan in Germany.MethodsMedication reconciliation was performed for hospitalized patients according to the Best Possible Medication History principle. The collected medication lists were analyzed for medication discrepancies and conformance with the statutory regulations. The medication discrepancies were (1) omitted drugs, (2) additional drugs, and (3) dosing errors.ResultsAfter hospitalization, 524 patients taking drugs were included. The majority (n = 424 patients) were eligible for a medication plan. While 241 medication lists were present, only 24.1% (n = 58) matched the federal standard format. The mean number of drugs was 6.3 ± 3.6, with 3315 medications (3046 long-term and 269 as needed) reconciled totally. The 84 medication lists with omitted or additional drugs included 166 medication discrepancies upon 774 drugs listed. Of the 253 patients with dosing errors, 146 had a medication list. Inappropriate dosages were due to single dose (n = 195), daily dose (n = 225) or frequency of application (n = 255).ConclusionMedication plans are valuable tools for patients and health care providers. This study shows that the introduced paper-based federal standard medication plan in Germany falls short of its expectations regarding availability and correctness. Switching to an electronic patient record system may overcome some of the current pitfalls. 相似文献
46.
Andressa P. Oliveira Fernando M. Simabuco Rodrigo E. Tamura Manuel C. Guerrero Paulo G.G. Ribeiro Towia A. Libermann Luiz F. Zerbini Armando M. Ventura 《Virus research》2013
Characterization of Human Respiratory Syncytial Virus (HRSV) protein interactions with host cell components is crucial to devise antiviral strategies. Viral nucleoprotein, phosphoprotein and matrix protein genes were optimized for human codon usage and cloned into expression vectors. HEK-293T cells were transfected with these vectors, viral proteins were immunoprecipitated, and co-immunoprecipitated cellular proteins were identified through mass spectrometry. Cell proteins identified with higher confidence scores were probed in the immunoprecipitation using specific antibodies. The results indicate that nucleoprotein interacts with arginine methyl-transferase, methylosome protein and Hsp70. Phosphoprotein interacts with Hsp70 and tropomysin, and matrix with tropomysin and nucleophosmin. Additionally, we performed immunoprecipitation of these cellular proteins in cells infected with HRSV, followed by detection of co-immunoprecipitated viral proteins. The results indicate that these interactions also occur in the context of viral infection, and their potential contribution for a HRSV replication model is discussed. 相似文献
47.
目的建立孕妇胎盘MRI检查的护理措施,以提高孕妇完成MRI检查的依从性和有效性。方法其中80例孕妇采取普通检查程序(为对照组),包括预约-准备-检查。80例孕妇采取改进的护理方案(为实验组),包括预约-宣教-答疑-准备-检查。数据资料进行描述性统计分析。结果实验组孕妇的检查时间明显少于对照组,均一次性成功完成检查。对照组中的6例出现喘憋,呕吐等症状,在护士安抚干预后,于第二次配合完成检查。2例因严重的恐惧幽闭症未完成MRI检查。结论健全的护理方案对孕妇MRI检查的依从性和有效性具有重要作用。 相似文献
48.
通过对束流匹配的加速器进行计划设计,比较计划参数,验证交叉执行的差异及通过率,验证束流匹配的可行性及可靠性。选取头颈、胸部和腹盆部共15例病例,分别设计Clinac iX和Trilogy两个不同治疗机的三维适形计划(3D-CRT);另选头颈、胸部和腹盆部共15例病例,分别设计两个不同治疗机的调强计划(IMRT)。比较相同计划类型不同治疗机的计划差异,评价指标包括靶区PTV的D98%、D2%、Dmax,晶体Dmax、脑干Dmax、左右肺V5 Gy、双肺V20 Gy、脊髓Dmax、膀胱D50%、小肠D2 cc、股骨头V40 Gy等危及器官及治疗机跳数MU。并对治疗机执行计划进行点剂量和面剂量验证。PTV的D98%、D2%、Dmax剂量差异最大平均值标准差分别为-0.52%±0.30%、0.53%±0.45%、-0.55%±0.17%,危及器官剂量差异最大平均值为膀胱D50%(0.94%±0.84%);Clinac iX和Trilogy治疗机执行所有计划的最大绝对剂量偏差分别为2.36%和-2.80%。MatriXX和PV的γ验证通过率结果平均值分别在97.00%和96.00%以上,Clinac iX最小值为95.40%,Trilogy最小值为95.90%。两台经过束流匹配的治疗机之间交换执行计划的剂量学偏差在临床可接受的范围内,各项参数能精准执行,必要时可以在两台治疗机之间交换执行计划,保证病人放疗疗程完整。 相似文献
49.
50.
Takaaki Konishi Michimasa Fujiogi Nobuaki Michihata Kojiro Morita Hiroki Matsui Kiyohide Fushimi Masahiko Tanabe Yasuyuki Seto Hideo Yasunaga 《Journal of infection and chemotherapy》2021,27(5):690-695
IntroductionSome clinicians administer antibiotics in adhesive SBO treatment to prevent bacterial translocation without evidence confirming reduced sepsis and mortality. We aimed to evaluate the effectiveness of preventive antibiotic administration in nonoperative treatment of adhesive small bowel obstruction (SBO) in a retrospective study.MethodsUsing a Japanese national inpatient database, we identified 114,786 eligible patients with adhesive SBO and divided patients into a group who did not receive intravenous antibiotics in the initial 2 consecutive days after admission (control group, n = 71,666) and a group who received intravenous antibiotics ≥2 days after admission (antibiotic group, n = 43,120). To compare the in-hospital mortality, occurrence of sepsis, septic shock, Clostridioides difficile colitis, length of stay, and total costs between the two groups, we performed instrumental variable analyses to adjust for measured and unmeasured confounding factors.ResultsOverall, in-hospital mortality was 2.2%, and the occurrence of sepsis was 0.8%. In the instrumental variable analyses, no significant differences were found for in-hospital mortality, occurrence of sepsis, septic shock, Clostridioides difficile colitis, or total hospitalization costs. The antibiotic group showed a longer length of stay than the control group (coefficient, 1.9 days; 95% confidence interval, 0.6–3.2).ConclusionsIn this large nationwide cohort of patients with adhesive SBO, we found no benefit regarding preventive antibiotic administration in nonoperative treatment; however, antibiotic administration was associated with a longer hospital stay. These results did not support routine administration of antibiotics at admission to prevent bacterial translocation. 相似文献